ALPHA-HAEMOLYSIN-VARIANTEN MIT VERÄNDERTEN EIGENSCHAFTEN

European patent · EP3212810 · In force

Register entry

Publication number
EP3212810
Application number
EP15855632
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 28, 2015
Published
Sep 6, 2017
Granted
Jan 1, 2020
Protection ends at the latest
Oct 27, 2035
Next annual fee due
Oct 31, 2027
IPC classes
C12Q 1/68 (2018.01)
C07K 14/31 (2006.01)
C12Q 1/6869 (2018.01)
Priority
US 201462073936 P 31.10.2014
PCT application
PCT/US2015/057902 28.10.2015
PCT publication
WO2016/069806 06.05.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. Nov 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.10.2025 → 31.10.2026

    Published in Swissreg on 01.11.2025

  3. Nov 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.10.2024 → 31.10.2025

    Published in Swissreg on 01.11.2024

  4. Sep 5, 2024

    Transferred

    Owner
    Genia Technologies, Inc., 2841 Scott Boulevard, Santa Clara, CA 95050, USA → F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel

    Published in Swissreg on 05.09.2024

  5. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  6. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  7. Jan 1, 2020

    Granted

    Published in Swissreg on 01.01.2020

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

KORENBLUM, Daniel

Mountain View, CA 94043, US

DORWART, Michael

San Jose, CA 95112, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.